NCT01436838View on ClinicalTrials.gov

China Betaferon Adherence, Coping and Nurse Support Study

CompletedOBSERVATIONAL

Enrollment

110

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

September 30, 2015

Study Completion Date

December 31, 2015

Conditions

Multiple Sclerosis, Chronic Progressive

Interventions

DRUG

Interferon beta-1b (Betaseron, BAY86-5046)

All patients will be prescribed with Betaseron and be instructed on treatment by their phisicians

Trial Locations (1)

Unknown

Many Locations

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Bayer

INDUSTRY

NCT01436838 - China Betaferon Adherence, Coping and Nurse Support Study | Biotech Hunter | Biotech Hunter